Melanotan II

Melanotan II is a synthetic cyclic heptapeptide derived from the naturally occurring melanocortin peptide, α-MSH. Its molecular structure, specifically the cyclic lactam bridge between Asp4 and Lys10, confers enhanced stability and receptor selectivity compared to its linear counterpart. This structural modification allows for sustained engagement with melanocortin receptors, particularly MC1, MC3, MC4, and MC5 receptors, making it a valuable tool for in vitro and in vivo research models. The research history of Melanotan II traces back to efforts to develop stable and potent melanocortin receptor agonists. Its design aimed to improve upon the pharmacokinetic properties of α-MSH, offering a more robust compound for experimental studies. Early investigations focused on its binding affinity and functional activity at various melanocortin receptor subtypes, elucidating its role as a non-selective agonist. Biochemically, Melanotan II functions by activating melanocortin receptors, initiating intracellular signaling cascades that are dependent on the specific receptor subtype and cell type under investigation. Research applications primarily involve exploring the physiological roles of the melanocortin system, including studies on pigmentation mechanisms, energy homeostasis, and central nervous system functions. Its well-defined structure and established receptor interactions make it a standard reference compound in melanocortin research.